O'Shaughnessy Asset Management’s Pacira BioSciences PCRX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587K	Buy	+23,153	New	+$547K	﹤0.01%	1525
2022 Q1	–	Sell	-3,606	Closed	-$217K	–	1340
2021 Q4	$217K	Hold	3,606	–	–	﹤0.01%	1024
2021 Q3	$202K	Sell	3,606 -1,104	-23%	-$63.6K	﹤0.01%	1040
2021 Q2	$286K	Sell	4,710 -10	-0.2%	-$633	0.01%	876
2021 Q1	$331K	Sell	4,720 -36	-0.8%	-$2.57K	0.01%	742
2020 Q4	$285K	Buy	4,756 +409	+9%	+$23.9K	0.01%	708
2020 Q3	$262K	Buy	+4,347	New	+$253K	0.01%	620

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

O'Shaughnessy Asset Management's PCRX Position: Q2 2026 in Review

O'Shaughnessy Asset Management opened a new position in Pacira BioSciences (PCRX) in Q2 2026: 23,153 shares worth $587K. The stake represents ﹤0.01% of the portfolio and ranks #1525 among its holdings. This is a return to the name: O'Shaughnessy Asset Management previously reported a position in PCRX as recently as Q4 2021.

O'Shaughnessy Asset Management first reported a position in PCRX in Q3 2020 and has held it in 7 quarters since. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

O'Shaughnessy Asset Management held 23,153 shares of Pacira BioSciences worth $587K as of Q2 2026.
Pacira BioSciences was a new O'Shaughnessy Asset Management position in Q2 2026.
Pacira BioSciences made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1525 holding.
O'Shaughnessy Asset Management first reported a position in Pacira BioSciences in Q3 2020 and has held it in 7 quarters since.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.